• Press Release

BIA welcomes new NIHR framework for restarting research activities in the UK

Commenting on the NIHR 'Framework for restart' released today, Steve Bates OBE, Chief Executive of the BIA said: 

BIA responds to government approach to Northern Ireland Protocol

Commenting on the Government’s approach to the Northern Ireland Protocol released yesterday, Steve Bates OBE, Chief Executive of the BioIndustry Association said:

BIA welcomes financial support for biotechs during COVID-19 disruption

A new support fund for innovative firms struggling to access equity finance during the COVID-19 disruption has opened for applications today (20 May). The Future Fund, run by the British Business Bank, will provide convertible loans of between £125,000 and £5m to businesses if they can also secure matched funding from third-party investors.

BIA responds to publication of draft UK-EU free trade agreement

Commenting on the publication of draft UK-EU free trade agreement text released today Steve Bates OBE, Chief Executive of the BIA said:

BIA responds to cash injection of €117m to eight coronavirus projects by the European Commission

Commenting on today’s announcement of €117 million awarded to eight coronavirus projects by the European Commission, Steve Bates OBE, Chief Executive of the BIA said:

Health Secretary pays tribute to UK life sciences companies, as testing ramps up for COVID-19

Commenting on the day of the 100,000 testing target, Steve Bates OBE, Chief Executive of the BIA said: “It’s gratifying to see the Government recognises the major role the UK life sciences industry has played in the collaborative, speedy and innovative national effort to increase testing capability.

BIA industry-led vaccine manufacturing taskforce welcomes collaboration announcement between AstraZeneca and the Jenner Institute on developing a COVID-19 vaccine

Steve Bates OBE, Chief Executive of the BIA said: “UK life sciences companies already working on key elements of manufacturing, through the BIA taskforce, look forward to working with AstraZeneca on the vital development and scale up of the Jenner COVID-19 vaccine.

BIA welcomes further funding for both Imperial and Oxford COVID-19 clinical trials and manufacturing capability

Responding to the funding announcement at today’s Downing Street COVID-19 briefing by the Health Secretary Matt Hancock, for Imperial College London and Oxford University, Steve Bates OBE, Chief Executive of the BioIndustry Association (BIA) said:

BIA welcomes £1 billion support package for innovative companies

Commenting on today’s announcement from the Chancellor, BIA CEO Steve Bates OBE said:

BIA industry-led vaccine manufacturing group welcomes funding announcement of £14m from UK government, to help rapidly scale up COVID-19 vaccines

A BIA industry-led vaccine manufacturing group has welcomed today’s announcement by the Business Secretary, Alok Sharma of a £14 million investment pot, to rapidly progress treatments and vaccines. The money announced will support the manufacturing process of COVID-19 vaccines.